p21 Disrupts the interaction between cdk2 and the E2F-p130 complex

Molecular and Cellular Biology

Volumn 16, Issue 3, 1996, Pages 737-744

  Shiyanov, Pavel ^a   Bagchi, Srilata ^a   Adami, Guy ^a   Kokontis, John ^b   Hay, Nissim ^b   Arroyo, May ^a   Morozov, Alexei ^a   Raychaudhuri, Pradip ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P21; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0029670837     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.3.737     Document Type: Article

References (75)

1. Arroyo, M., S. Bagchi, and P. Raychaudhuri. 1993. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol. Cell. Biol. 13:6537-6546.
2. Arroyo, M., and P. Raychaudhuri. 1992. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein. Nucleic Acids Res. 20:5947-5954.
3. Bagchi, S., R. Weinmann, and P. Raychaudhuri. 1991. The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65:1063-1072.
4. Bandara, L. R., and N. B. LaThangue. 1991. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494-497.
5. Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680-2690.
6. Blake, M., and J. C. Azizkhan. 1989. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9:4994-5002.
7. Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (London) 355:176-179.
8. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061
9. Chen, P., P. Scully, J. Shew, J. Y. J. Wang, and W. Lee. 1989 Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
10. Chittenden, T., D. M. Livingston, and W. G. Kaelin, Jr. 1991 The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein Cell 65:1085-1095
11. Cobrinik, D., P. Whyte, D. Peeper, T. Jacks, and R. Weinberg. 1993. Cell cycle-specific association of E2F with p130 E1A-binding protein. Genes Dev. 7:2392-2404.
12. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797-1804.
13. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D. M. Livingston. 1989 The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
14. Devoto, S. H., M. Mudryj, J. Pines, T. Hunter, and J. R. Nevins. 1992. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity p33 cdk2 is a component of the E2F-cyclin A complex. Cell 68:167-176.
15. Dulic, V., W. K. Kaufman, S. Wilson, T. D. Tilsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994 p53-dependent inhibition of cyclin dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
16. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes Genes Dev. 8:1772-1786
17. Dyson, N., M. Dembski, A. Fattaey, C. Ngwu, M. Ewen, and K. Helin. 1993 Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F1 J. Virol 67:7641-7647.
18. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
19. Ewen, M., B. Faha, E. Harlow, and D. M. Livingston. 1992. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255:85-90.
20. Ginsberg, D., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. E. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
21. Girling, R., J. Patridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. La Thangue. 1993. A new component of the transcription factor DRTF1/E2F. Nature (London) 362:83-87.
22. Gu, Y., C. T. Turck, and D. O. Morgan. 1993. Inhibition of cdk2 activity in vivo by an associated 20K regulatory subunit. Nature (London) 366:707-710.
23. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2F-containing promoters EllaE, c-myc, RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431-3438.
24. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with cdk2 and cyclins. Genes Dev. 7:2378-2391.
25. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
26. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993 The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
27. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
28. Helin, K., and E. Harlow. 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3:43-46.
29. Herber, B., M. Truss, M. Beato, and R. Muller. 1994. Indicible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-1304.
30. Herzinger, T., D. A. Wolf, D. Eick, and P. Kind. 1995. The pRb-related protein p130 is a possible effector of transforming growth factor β1 induced cell cycle arrest in keratinocytes. Oncogene 10:2079-2084.
31. Hiebert, S. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRB-mediated growth suppression Mol. Cell. Biol. 13:3384-3391.
32. Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185.
33. Hiebert, S. W., M. Lipp, and J. R. Nevins. 1989. E1A-dependent transactivation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA 86:3594-3598.
34. Hsiao, K.-M., S. L. McMahon, and P. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526-1537.
35. Huber, H. E., G. Edwards, P. J. Goodhart, D. R. Patrick, P. S. Huang, M. Ivey-Hoyle, S. F. Barnett, A. Oliff, and D. C. Heimbrook. 1993. Transcription factor E2F binds DNA is a heterodimer Proc. Natl. Acad. Sci. USA 90: 3525-3529
36. Hunter, T., and J. Pines. 1991. Cyclins and cancer. Cell 66:1071-1074.
37. Isaacs, W. B., B. S. Carter, and C. M. Ewing. 1991. Wild-type p53 suppresses growth of human prostate concer cells containing mutant p53 alleles. Cancer Res. 51:4716-4720.
38. Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression Genes Dev 8:1514-1525.
39. Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364
40. Kokontis, J. M., A. J. Wagner, S. Liao, and N. Hay. 1995 Unpublished data.
41. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994 Negative regulation of the growth promoting transcription factor E2F1 by a stably bound cyclin A-dependent protein kinase Cell 78:161-172.
42. Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members Science 262:1557-1560.
43. Lam, E. W.-F., and R. J. Watson. 1993 An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705-2713
44. La Thangue, N. B. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci. 19:108-114.
45. Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclinA/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1874-1885.
46. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
47. Li, Y., C. Graham, S. Lacy, M. V. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
48. Mayol, X., X. Grana, A. Baldi, N. Sang, Q. Hu, and A. Giordano. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which bind to ElA transforming domain. Oncogene 8:2561-2566.
49. Means, A. L., J. E. Slanski, S. L. McMahon, M. W. Knuth, and P. J. Faraham. 1992 The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 12:1054-1063.
50. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3:63-70.
51. Morosov, A., W. C. Phelps, and P. Raychaudhuri. 1994. Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60 J. Biol. Chem. 269:18434-18440.
52. Mudryj, M., S. H. Devoto, S. W. Hiebert, T. Hunter, J. Pines, and J. R. Nevins. 1991. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65:1243-1253
53. Mudryj, M., S. W. Hiebert, and J. R. Nevins. 1990. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9:2179-2184.
54. Nakanishi, M., R. S. Robetorye, G. R. Adami, O. M. Pereira-Smith, and J. R. Smith. 1995. Identification of the active region of the DNA synthesis inhibitory gene p21 Sdi/CIF1/WAF1. EMBO J. 14:555-563.
55. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429
56. Pearson, B. E., H.-P. Nasheuer, and T. S.-F. Wang. 1991. Human DNA polymerase a gene: sequences controlling expression in cycling and serum-stimulated cells. Mol. Cell. Biol. 11:2081-2095.
57. Qin, X.-Q., T. Chittenden, D. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
58. Raychaudhuri, P., S. Bagchi, S. D. Neill, and J. R. Nevins. 1990. Activation of E2F transcription factor in adenovirus-infected cells involves E1A-dependent stimulation of DNA-binding activity and induction of cooperative binding mediated by an E4 gene product. J. Virol 64:2702-2710.
59. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. Weinberg. 1995. E2F-4, and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad Sci. USA 92:2403-2407.
60. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J 12:1013-1020.
61. Shan, B., X. Zhu, P.-L. Chen, T. Durfee, Y. Yang, D. Sharp, and W.-H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F Mol. Cell. Biol 13:1610-1618.
62. Shin, E. K., A. Shin, C. Paulding, B. Schaffhausen, and A. S. Yee. 1995. Multiple changes in E2F function and regulation occur upon muscle differentiation Mol. Cell. Biol. 15:2252-2262.
63. Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
64. Slansky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. 1993. A protein synthesis dependent increase in E2F1 mRNA correlates with growth regulation of the DHFR promoter. Mol. Cell. Biol. 13:1610-1618.
65. Smith, E. J., and J. R. Nevins. 1995. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2. Mol. Cell. Biol. 15:338-344.
66. Thalmeier, K., H. Synovzik, R. Mertz, E.-L. Winnacker, and M. Lipp. 1989. Nuclear factor E2F mediates basic transcription and tram-activation by E1A of the human MYC promoter. Genes Dev. 3:527-536.
67. Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma family members. Genes Dev. 9:869-881
68. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (London) 358:259-261.
69. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701-704.
70. Yamamoto, M., M. Yoshida, K. Ono, T. Fujita, N. Ohtani-Fujita, T. Sakai, and T. Nikiado. 1994 Effect of tumor suppressors on cell cycle regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppress cyclin A expression. Exp. Cell Res 210:2061-2068.
71. Zamanian, M., and N. B. La Thangue. 1993. Transcriptional repression by the Rb-related protein p107 Mol. Biol. Cell 4:389-396.
72. Zhang, H., G. J. Hannon, and D. Beach, 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.
73. Zhu, L., G. Enders, J. A. Lees, R. L. Beijersbergen, R. Bernards, and E. Harlow. 1995. The RB-related protein p107 contains two growth suppression domains, independent interactions with E2F and cyclin/cdk2 complexes. EMBO J. 14:1904-1913.
74. Zhu, L., E. Harlow, and B. D. Dynlacht. 1995. p107 uses a p21 CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.
75. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.